{"total":68,"page":1,"pageSize":25,"pages":3,"millis":0,"query":{"q":"","state":"","metro":"","industry":"","agency":"","kind":"","level":"federal","type":"","quarter":"2021Q3","grade":"","collection":"AGY-FED-HEALTH-OTHER","from":"","to":"","sort":"relevance"},"items":[{"id":"AGY-FED-HEALTH-OTHER-038","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Determination of Public Health Emergency and Declaration that circumstances exist justifying emergency use of in vitro diagnostics, 85 Fed. Reg. 7316 (Feb. 7, 2020)","title":"Determination of Public Health Emergency","dateIssued":"2020-02-04","startDate":"2020-02-04","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["EMER","SUPPLY"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-038","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-038"},{"id":"AGY-FED-HEALTH-OTHER-040","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar. 17, 2020)","title":"Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19","dateIssued":"2020-03-10","startDate":"2020-02-04","endDate":"2020-10-20","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","EMER","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-040","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-040"},{"id":"AGY-FED-HEALTH-OTHER-124","kind":"order","level":"federal","jurisdiction":"United States (federal); Centers for Disease Control and Prevention, HHS","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Centers for Disease Control and Prevention, HHS (Alex M. Azar II, Secretary)","instrument":"Interim Final Rule, Control of Communicable Diseases; Foreign Quarantine (requirements for airlines to collect and transmit designated passenger and crew information), 85 Fed. Reg. 7874 (Feb. 12, 2020)","title":"Control of Communicable Diseases; Foreign Quarantine","dateIssued":"2020-02-12","startDate":"2020-02-07","endDate":"2021-10-25","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["TRAV","EMP"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-124","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-124"},{"id":"AGY-FED-HEALTH-OTHER-125","kind":"order","level":"federal","jurisdiction":"United States (federal); Centers for Disease Control and Prevention, HHS","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Robert R. Redfield, M.D., Director, CDC","instrument":"Agency Order, Collection of Certain Data Regarding Passengers and Crew Arriving From Foreign Countries by Airlines (issued Feb. 18, 2020), 85 Fed. Reg. 10439 (Feb. 24, 2020)","title":"Collection of Certain Data Regarding Passengers and Crew Arriving From Foreign Countries by Airlines","dateIssued":"2020-02-18","startDate":"2020-02-18","endDate":"2021-11-08","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["TRAV","EMP"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-125","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-125"},{"id":"AGY-FED-HEALTH-OTHER-032","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, HHS","instrument":"Policy for Diagnostics Testing in Laboratories Certified To Perform High Complexity Testing Under CLIA Prior to Emergency Use Authorization for Coronavirus Disease-2019 During the Public Health Emergency; Immediately in Effect Guidance, 85 Fed. Reg. 13138 (Mar. 6, 2020)","title":"Policy for Diagnostics Testing in Laboratories Certified To Perform High Complexity Testing Under the Clinical Laboratory Improvement Amendments Prior to Emergency Use Authorization for Coronavirus Disease-2019","dateIssued":"2020-02-29","startDate":"2020-02-29","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-032","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-032"},{"id":"AGY-FED-HEALTH-OTHER-039","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Emergency Use Declaration (personal respiratory protective devices), 85 Fed. Reg. 13907 (Mar. 10, 2020)","title":"Emergency Use Declaration","dateIssued":"2020-03-02","startDate":"2020-03-02","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","EMER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-039","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-039"},{"id":"AGY-FED-HEALTH-OTHER-052","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Jacqueline A. O\u0027Shaughnessy, Acting Chief Scientist, FDA (letter to CDC)","instrument":"Emergency Use Authorization: NIOSH-approved air purifying respirators for health care personnel (issued Mar. 2, 2020; reissued Mar. 28, 2020 and July 12, 2021)","title":"Letter of Authorization to CDC, NIOSH-Approved Air Purifying Respirators (reissued July 12, 2021)","dateIssued":"2021-07-12","startDate":"2020-03-02","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-052","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-052"},{"id":"AGY-FED-HEALTH-OTHER-008","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA (letter to Assistant Secretary Elinore McCance-Katz, SAMHSA)","instrument":"DEA-DC-015, Exception to 21 C.F.R. 1301.74(h) for Narcotic Treatment Programs (take-home delivery by NTP staff, law enforcement or National Guard)","title":"SAMHSA Exemption - NTP Deliveries (Coronavirus)","dateIssued":"2020-03-16","startDate":"2020-03-16","endDate":"2023-05-11","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-008","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-008"},{"id":"AGY-FED-HEALTH-OTHER-009","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Drug Enforcement Administration, Diversion Control Division (with the HHS Secretary\u0027s designation of Mar. 16, 2020)","instrument":"DEA-DC-016, COVID-19 Information Page: Telemedicine (designation that the section 802(54)(D) telemedicine allowance applies to all schedule II-V controlled substances in all areas of the United States)","title":"Use of Telemedicine While Providing Medication Assisted Treatment / COVID-19 Telemedicine (updated)","dateIssued":"2020-03-16","startDate":"2020-03-16","endDate":"2023-05-10","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-009","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-009"},{"id":"AGY-FED-HEALTH-OTHER-026","kind":"order","level":"federal","jurisdiction":"United States (federal); Substance Abuse and Mental Health Services Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"SAMHSA (Assistant Secretary for Mental Health and Substance Use)","instrument":"Opioid Treatment Program (OTP) Guidance (Mar. 16, 2020; updated Mar. 19, 2020): blanket take-home exceptions","title":"Opioid Treatment Program (OTP) Guidance","dateIssued":"2020-03-16","startDate":"2020-03-16","endDate":"2021-11-18","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-026","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-026"},{"id":"AGY-FED-HEALTH-OTHER-001","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office for Civil Rights","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Roger T. Severino, Director, Office for Civil Rights, HHS","instrument":"Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency, 85 Fed. Reg. 22024 (Apr. 21, 2020)","title":"Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency","dateIssued":"2020-03-17","startDate":"2020-03-17","endDate":"2023-05-11","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-001","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-001"},{"id":"AGY-FED-HEALTH-OTHER-086","kind":"context","level":"federal","jurisdiction":"United States (federal); Social Security Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Social Security Administration (Andrew Saul, Commissioner; press release by Mark Hinkle, Acting Press Officer)","instrument":"Press release of Mar. 16, 2020: \u0027Effective March 17, 2020, Social Security Offices Will Only Offer Phone Service\u0027","title":"Effective March 17, 2020, Social Security Offices Will Only Offer Phone Service ** Online Services Remain Available **","dateIssued":"2020-03-16","startDate":"2020-03-17","endDate":"2022-04-07","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["CRT","CLOSE","TELE"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-086","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-086"},{"id":"AGY-FED-HEALTH-OTHER-027","kind":"context","level":"federal","jurisdiction":"United States (federal); Substance Abuse and Mental Health Services Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"SAMHSA","instrument":"COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance","title":"COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance","dateIssued":"2020-03-19","startDate":"2020-03-19","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-027","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-027"},{"id":"AGY-FED-HEALTH-OTHER-041","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Drug Evaluation and Research","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDER","instrument":"Guidance for Industry: Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) (Mar. 19, 2020; updated Mar. 27 and Apr. 15, 2020, and later)","title":"Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19)","dateIssued":"2020-03-19","startDate":"2020-03-19","endDate":"2021-12-31","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-041","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-041"},{"id":"AGY-FED-HEALTH-OTHER-067","kind":"context","level":"federal","jurisdiction":"United States (federal); Department of Veterans Affairs, Veterans Benefits Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Department of Veterans Affairs, Veterans Benefits Administration","instrument":"VA announcement of Mar. 31, 2020: VBA closed its 56 regional offices to the public Mar. 19, 2020; benefit briefings on military installations discontinued Mar. 30, 2020; services shifted to telephone and virtual channels","title":"VA expands virtual services to support Veterans amid regional office closures due to COVID-19 pandemic","dateIssued":"2020-03-31","startDate":"2020-03-19","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["CRT","TELE"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-067","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-067"},{"id":"AGY-FED-HEALTH-OTHER-010","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-017 (DEA065), Dear Registrant letter on early refills and 90-day supplies of controlled substances during the COVID-19 emergency","title":"Early RX Refill (OMB 3-20-20)","dateIssued":"2020-03-20","startDate":"2020-03-20","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-010","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-010"},{"id":"AGY-FED-HEALTH-OTHER-012","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA (letter to the Healthcare Distribution Alliance)","instrument":"DEA-DC-019 (DEA066), letter granting an exception permitting transmission of DEA Form 222 by fax or scan during the COVID-19 emergency","title":"Fax/Scan 222 (final) Esign","dateIssued":"2020-03-20","startDate":"2020-03-20","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-012","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-012"},{"id":"AGY-FED-HEALTH-OTHER-043","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Devices and Radiological Health","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDRH","instrument":"Guidance for Industry and FDA Staff: Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (March 2020)","title":"Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency","dateIssued":"2020-03-22","startDate":"2020-03-22","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-043","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-043"},{"id":"AGY-FED-HEALTH-OTHER-036","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Emergency Use Authorization Declaration (medical devices, including alternative products used as medical devices), 85 Fed. Reg. 17335 (Mar. 27, 2020)","title":"Emergency Use Authorization Declaration","dateIssued":"2020-03-24","startDate":"2020-03-24","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","EMER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-036","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-036"},{"id":"AGY-FED-HEALTH-OTHER-042","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Drug Evaluation and Research","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDER","instrument":"Guidance for Industry: Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) (Mar. 24, 2020; updated Mar. 27 and Apr. 15, 2020, and later)","title":"Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19)","dateIssued":"2020-03-24","startDate":"2020-03-24","endDate":"2021-12-31","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-042","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-042"},{"id":"AGY-FED-HEALTH-OTHER-049","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Denise M. Hinton, Chief Scientist, FDA","instrument":"Emergency Use Authorization: Imported, Non-NIOSH-Approved Disposable Filtering Facepiece Respirators (issued Mar. 24, 2020; reissued Mar. 28, 2020, May 7, 2020 and Mar. 24, 2021; revoked July 6, 2021)","title":"Letter of Authorization, Imported Non-NIOSH-Approved Disposable Filtering Facepiece Respirators (reissued Mar. 24, 2021)","dateIssued":"2021-03-24","startDate":"2020-03-24","endDate":"2021-07-06","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-049","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-049"},{"id":"AGY-FED-HEALTH-OTHER-051","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Denise M. Hinton, Chief Scientist, FDA","instrument":"Emergency Use Authorization: Ventilators, anesthesia gas machines modified for use as ventilators, positive pressure breathing devices modified for use as ventilators, ventilator tubing connectors and ventilator accessories (Mar. 24, 2020)","title":"Letter of Authorization to Manufacturers and Other Stakeholders: Ventilators","dateIssued":"2020-03-24","startDate":"2020-03-24","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-051","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-051"},{"id":"AGY-FED-HEALTH-OTHER-011","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-018 (DEA067), Dear Registrant letter granting an exception to separate State registration for practitioners dispensing in additional States during the COVID-19 emergency","title":"DEA State Reciprocity (final) (Signed)","dateIssued":"2020-03-25","startDate":"2020-03-25","endDate":"","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-011","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-011"},{"id":"AGY-FED-HEALTH-OTHER-044","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Devices and Radiological Health","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDRH","instrument":"Guidance: Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Mar. 25, 2020; revised Apr. 2020, May 2020, Sept. 2021; superseded Sept. 5, 2023)","title":"Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency","dateIssued":"2020-03-25","startDate":"2020-03-25","endDate":"2023-09-05","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","MASK","OTHER"],"grade":"secondary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-044","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-044"},{"id":"AGY-FED-HEALTH-OTHER-131","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, HHS","instrument":"Notice, Process for Making Available Guidance Documents Related to Coronavirus Disease 2019, 85 Fed. Reg. 16949 (Mar. 25, 2020)","title":"Process for Making Available Guidance Documents Related to Coronavirus Disease 2019","dateIssued":"2020-03-25","startDate":"2020-03-25","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-131","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-131"}],"facets":{"kind":[{"value":"order","label":"Order","count":54},{"value":"context","label":"Context (guidance or announcement)","count":14}],"level":[{"value":"federal","label":"Federal","count":68}],"state":[],"type":[{"value":"OTHER","label":"Other","count":46},{"value":"HC","label":"Health care orders","count":41},{"value":"SUPPLY","label":"Supply chain","count":22},{"value":"TELE","label":"Telework mandate","count":12},{"value":"EMER","label":"Emergency declaration","count":6},{"value":"EMP","label":"Workplace rules","count":5},{"value":"SCH","label":"Schools and child care","count":4},{"value":"TRAV","label":"Travel and quarantine","count":3},{"value":"CRT","label":"Courts and public offices","count":2},{"value":"GATH","label":"Gathering cap","count":2},{"value":"MASK","label":"Face-covering requirement","count":2},{"value":"QUAR","label":"Quarantine and isolation","count":2},{"value":"VAX","label":"Vaccination or testing","count":2},{"value":"CAP","label":"Capacity limit","count":1},{"value":"CLOSE","label":"Business closure","count":1}],"quarter":[{"value":"2021Q3","label":"2021 Q3","count":68},{"value":"2021Q2","label":"2021 Q2","count":61},{"value":"2020Q4","label":"2020 Q4","count":59},{"value":"2021Q1","label":"2021 Q1","count":59},{"value":"2020Q3","label":"2020 Q3","count":54},{"value":"2020Q2","label":"2020 Q2","count":51}],"grade":[{"value":"primary","label":"Primary source read","count":66},{"value":"secondary","label":"Confirmed from a secondary source","count":2}],"industry":[],"agency":[{"value":"FED-HEALTH-OTHER","label":"Other federal health agencies","count":68}]}}